- Previous Close
0.00 - Open
16.75 - Bid 14.87 x --
- Ask 17.94 x --
- Day's Range
16.75 - 16.75 - 52 Week Range
13.30 - 25.00 - Volume
40 - Avg. Volume
3 - Market Cap (intraday)
2.438B - Beta (5Y Monthly) 1.91
- PE Ratio (TTM)
47.37 - EPS (TTM)
0.38 - Earnings Date Apr 16, 2025 - Apr 21, 2025
- Forward Dividend & Yield 0.10 (0.55%)
- Ex-Dividend Date May 2, 2025
- 1y Target Est
--
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.
www.vitrolife.comRecent News: VTRLY
View MorePerformance Overview: VTRLY
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VTRLY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VTRLY
View MoreValuation Measures
Market Cap
2.22B
Enterprise Value
2.31B
Trailing P/E
47.83
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.79
Price/Book (mrq)
1.80
Enterprise Value/Revenue
6.42
Enterprise Value/EBITDA
29.61
Financial Highlights
Profitability and Income Statement
Profit Margin
14.21%
Return on Assets (ttm)
2.93%
Return on Equity (ttm)
3.90%
Revenue (ttm)
3.61B
Net Income Avi to Common (ttm)
513M
Diluted EPS (ttm)
0.38
Balance Sheet and Cash Flow
Total Cash (mrq)
1.14B
Total Debt/Equity (mrq)
15.31%
Levered Free Cash Flow (ttm)
653.12M